| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Immunoglobulin Class Switching | 36 | 2015 | 83 | 7.460 |
Why?
|
| Cytidine Deaminase | 20 | 2015 | 86 | 4.920 |
Why?
|
| B-Lymphocytes | 29 | 2015 | 574 | 3.570 |
Why?
|
| Recombination, Genetic | 23 | 2015 | 246 | 2.550 |
Why?
|
| Immunoglobulin Switch Region | 13 | 2015 | 21 | 2.320 |
Why?
|
| Immunoglobulin Heavy Chains | 11 | 2015 | 46 | 1.630 |
Why?
|
| DNA Repair | 11 | 2014 | 236 | 1.470 |
Why?
|
| DNA-Binding Proteins | 16 | 2015 | 1184 | 1.390 |
Why?
|
| Immunoglobulin G | 8 | 2013 | 459 | 1.380 |
Why?
|
| Immunoglobulin A | 9 | 2009 | 97 | 1.290 |
Why?
|
| Immunoglobulin Isotypes | 8 | 2012 | 24 | 1.240 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 4 | 2014 | 15 | 1.190 |
Why?
|
| DNA Mismatch Repair | 4 | 2014 | 35 | 1.110 |
Why?
|
| DNA Breaks, Double-Stranded | 9 | 2015 | 86 | 1.060 |
Why?
|
| Gene Rearrangement, B-Lymphocyte | 4 | 2014 | 13 | 1.010 |
Why?
|
| DNA Polymerase beta | 3 | 2013 | 6 | 1.010 |
Why?
|
| Spleen | 10 | 2015 | 483 | 0.980 |
Why?
|
| DNA Glycosylases | 4 | 2014 | 13 | 0.930 |
Why?
|
| DNA-(Apurinic or Apyrimidinic Site) Lyase | 4 | 2014 | 25 | 0.920 |
Why?
|
| Mice | 47 | 2015 | 10827 | 0.920 |
Why?
|
| MutS Homolog 2 Protein | 10 | 2014 | 28 | 0.900 |
Why?
|
| Mice, Knockout | 19 | 2015 | 2107 | 0.870 |
Why?
|
| Animals | 55 | 2015 | 20634 | 0.830 |
Why?
|
| Uracil-DNA Glycosidase | 5 | 2011 | 9 | 0.820 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2014 | 131 | 0.760 |
Why?
|
| Proto-Oncogene Proteins | 8 | 2005 | 325 | 0.740 |
Why?
|
| Cell Cycle Proteins | 3 | 2015 | 394 | 0.740 |
Why?
|
| Endonucleases | 3 | 2014 | 83 | 0.710 |
Why?
|
| Lymphocyte Activation | 7 | 2014 | 760 | 0.710 |
Why?
|
| Base Pair Mismatch | 5 | 2005 | 36 | 0.700 |
Why?
|
| Genes, Immunoglobulin | 6 | 2002 | 34 | 0.680 |
Why?
|
| Gene Rearrangement | 2 | 2014 | 41 | 0.660 |
Why?
|
| Nuclear Proteins | 9 | 2015 | 780 | 0.610 |
Why?
|
| Mice, Inbred C57BL | 14 | 2015 | 3391 | 0.600 |
Why?
|
| Immunoglobulins | 3 | 2015 | 77 | 0.590 |
Why?
|
| DNA | 13 | 2015 | 832 | 0.550 |
Why?
|
| Cells, Cultured | 12 | 2015 | 2152 | 0.550 |
Why?
|
| DNA Repair Enzymes | 3 | 2003 | 37 | 0.550 |
Why?
|
| Interleukin-4 | 8 | 2007 | 141 | 0.540 |
Why?
|
| Germinal Center | 2 | 2014 | 40 | 0.510 |
Why?
|
| Mutation | 6 | 2014 | 2607 | 0.500 |
Why?
|
| DNA Damage | 4 | 2014 | 280 | 0.490 |
Why?
|
| Transforming Growth Factor beta | 4 | 2009 | 172 | 0.480 |
Why?
|
| Histones | 3 | 2014 | 483 | 0.470 |
Why?
|
| NF-kappa B | 4 | 1998 | 469 | 0.460 |
Why?
|
| Mutation Rate | 1 | 2013 | 23 | 0.420 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2013 | 34 | 0.420 |
Why?
|
| B-Lymphocyte Subsets | 3 | 2008 | 46 | 0.400 |
Why?
|
| Deoxyribonuclease (Pyrimidine Dimer) | 1 | 2012 | 2 | 0.390 |
Why?
|
| Neoplasm Proteins | 3 | 2003 | 281 | 0.380 |
Why?
|
| G1 Phase | 3 | 2012 | 56 | 0.380 |
Why?
|
| Base Sequence | 13 | 2007 | 1329 | 0.360 |
Why?
|
| Transcription, Genetic | 7 | 2012 | 879 | 0.350 |
Why?
|
| Adenosine Triphosphatases | 3 | 2003 | 255 | 0.340 |
Why?
|
| Molecular Sequence Data | 13 | 2007 | 1990 | 0.340 |
Why?
|
| Lipopolysaccharides | 6 | 2007 | 625 | 0.330 |
Why?
|
| Tandem Repeat Sequences | 5 | 2015 | 26 | 0.310 |
Why?
|
| DNA Breaks | 1 | 2009 | 8 | 0.310 |
Why?
|
| Adaptor Proteins, Signal Transducing | 6 | 2014 | 429 | 0.290 |
Why?
|
| Antioxidants | 1 | 2010 | 252 | 0.290 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2010 | 304 | 0.280 |
Why?
|
| CD40 Antigens | 2 | 1998 | 60 | 0.280 |
Why?
|
| Immunoglobulin Constant Regions | 3 | 2005 | 8 | 0.270 |
Why?
|
| Immunoglobulin mu-Chains | 2 | 2005 | 13 | 0.260 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2006 | 33 | 0.250 |
Why?
|
| Binding Sites | 6 | 2015 | 903 | 0.250 |
Why?
|
| Methyltransferases | 1 | 2006 | 62 | 0.250 |
Why?
|
| Models, Genetic | 4 | 2009 | 260 | 0.250 |
Why?
|
| Up-Regulation | 1 | 2007 | 373 | 0.240 |
Why?
|
| Repressor Proteins | 2 | 2011 | 347 | 0.240 |
Why?
|
| Interleukin-5 | 4 | 2007 | 36 | 0.230 |
Why?
|
| Gene Expression Regulation | 7 | 2013 | 1617 | 0.230 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2011 | 542 | 0.220 |
Why?
|
| Membrane Glycoproteins | 2 | 1998 | 668 | 0.220 |
Why?
|
| RNA Polymerase II | 1 | 2004 | 85 | 0.220 |
Why?
|
| Vertebrates | 1 | 2004 | 44 | 0.220 |
Why?
|
| Promoter Regions, Genetic | 3 | 1996 | 676 | 0.220 |
Why?
|
| N-Glycosyl Hydrolases | 1 | 2002 | 5 | 0.200 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2015 | 146 | 0.200 |
Why?
|
| Protein Binding | 4 | 2015 | 1602 | 0.200 |
Why?
|
| Gene Deletion | 2 | 2014 | 308 | 0.200 |
Why?
|
| Multifunctional Enzymes | 2 | 2014 | 17 | 0.190 |
Why?
|
| Evolution, Molecular | 1 | 2004 | 322 | 0.190 |
Why?
|
| MutL Protein Homolog 1 | 5 | 2014 | 27 | 0.190 |
Why?
|
| Flow Cytometry | 3 | 2011 | 661 | 0.190 |
Why?
|
| Amino Acid Substitution | 2 | 2015 | 240 | 0.180 |
Why?
|
| Cell Separation | 3 | 2011 | 147 | 0.180 |
Why?
|
| Humans | 18 | 2015 | 63293 | 0.180 |
Why?
|
| Genes, Switch | 2 | 1992 | 6 | 0.180 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 1 | 1999 | 3 | 0.150 |
Why?
|
| Exodeoxyribonucleases | 2 | 2009 | 29 | 0.150 |
Why?
|
| Mismatch Repair Endonuclease PMS2 | 3 | 2003 | 9 | 0.140 |
Why?
|
| RNA Splicing | 1 | 1999 | 162 | 0.140 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 2 | 2014 | 42 | 0.140 |
Why?
|
| Mice, Transgenic | 2 | 2015 | 1276 | 0.130 |
Why?
|
| Sequence Homology, Nucleic Acid | 3 | 2008 | 112 | 0.130 |
Why?
|
| Dextrans | 2 | 2007 | 46 | 0.130 |
Why?
|
| Lymphocyte Cooperation | 1 | 1996 | 30 | 0.130 |
Why?
|
| Trans-Activators | 1 | 1998 | 314 | 0.130 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 1996 | 109 | 0.120 |
Why?
|
| Mice, Inbred BALB C | 3 | 2008 | 881 | 0.120 |
Why?
|
| DNA, Complementary | 1 | 1996 | 165 | 0.120 |
Why?
|
| DNA, Intergenic | 1 | 2015 | 24 | 0.120 |
Why?
|
| Acetylation | 2 | 2007 | 122 | 0.120 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 2 | 1996 | 101 | 0.120 |
Why?
|
| DNA End-Joining Repair | 1 | 2015 | 23 | 0.120 |
Why?
|
| Genes, myc | 2 | 2012 | 18 | 0.120 |
Why?
|
| Antibody Formation | 1 | 1995 | 113 | 0.120 |
Why?
|
| Immunoglobulin epsilon-Chains | 1 | 1995 | 3 | 0.120 |
Why?
|
| Carrier Proteins | 4 | 2011 | 705 | 0.110 |
Why?
|
| Phosphorylation | 2 | 2014 | 937 | 0.110 |
Why?
|
| Gene Rearrangement, B-Lymphocyte, Heavy Chain | 3 | 2001 | 10 | 0.110 |
Why?
|
| Antigens, CD | 1 | 1996 | 347 | 0.110 |
Why?
|
| Mutation, Missense | 1 | 2015 | 186 | 0.110 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2014 | 21 | 0.110 |
Why?
|
| Tumor Suppressor p53-Binding Protein 1 | 1 | 2014 | 14 | 0.110 |
Why?
|
| Primary Cell Culture | 1 | 2014 | 78 | 0.110 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2014 | 39 | 0.110 |
Why?
|
| Fanconi Anemia Complementation Group Proteins | 1 | 2014 | 34 | 0.110 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 1993 | 22 | 0.110 |
Why?
|
| BRCA1 Protein | 1 | 2014 | 58 | 0.110 |
Why?
|
| Antibodies, Anti-Idiotypic | 3 | 2007 | 33 | 0.100 |
Why?
|
| Feedback, Physiological | 1 | 2013 | 58 | 0.100 |
Why?
|
| Point Mutation | 1 | 2013 | 166 | 0.100 |
Why?
|
| Embryo, Mammalian | 1 | 2013 | 156 | 0.100 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2014 | 172 | 0.100 |
Why?
|
| Mice, Mutant Strains | 3 | 2014 | 302 | 0.100 |
Why?
|
| Peptide Fragments | 1 | 2014 | 410 | 0.100 |
Why?
|
| S Phase | 1 | 2012 | 77 | 0.090 |
Why?
|
| Immunoglobulin gamma-Chains | 1 | 1992 | 5 | 0.090 |
Why?
|
| RNA, Messenger | 2 | 1996 | 1539 | 0.090 |
Why?
|
| Gene Knockout Techniques | 1 | 2012 | 95 | 0.090 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2014 | 337 | 0.090 |
Why?
|
| Cell Line | 5 | 2014 | 2037 | 0.090 |
Why?
|
| DNA Replication | 2 | 2014 | 235 | 0.090 |
Why?
|
| DNA, Superhelical | 1 | 2011 | 4 | 0.090 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 207 | 0.090 |
Why?
|
| DNA Primers | 3 | 2007 | 291 | 0.090 |
Why?
|
| Transcription Factors | 2 | 1998 | 1514 | 0.090 |
Why?
|
| Recombinant Fusion Proteins | 3 | 1998 | 489 | 0.090 |
Why?
|
| RNA Stability | 1 | 2011 | 102 | 0.080 |
Why?
|
| Cloning, Molecular | 5 | 1996 | 382 | 0.080 |
Why?
|
| RNA | 3 | 2008 | 423 | 0.080 |
Why?
|
| Genes, Regulator | 1 | 1990 | 28 | 0.080 |
Why?
|
| Reactive Oxygen Species | 1 | 2010 | 224 | 0.080 |
Why?
|
| Blotting, Western | 1 | 2010 | 608 | 0.080 |
Why?
|
| History, 21st Century | 1 | 2009 | 171 | 0.070 |
Why?
|
| Alternative Splicing | 1 | 2008 | 127 | 0.070 |
Why?
|
| Cell Proliferation | 1 | 2012 | 985 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-rel | 2 | 1998 | 16 | 0.070 |
Why?
|
| History, 20th Century | 1 | 2009 | 231 | 0.070 |
Why?
|
| In Vitro Techniques | 2 | 2002 | 488 | 0.070 |
Why?
|
| CD40 Ligand | 2 | 1998 | 158 | 0.070 |
Why?
|
| Cytosine | 1 | 2007 | 31 | 0.070 |
Why?
|
| Uracil | 1 | 2007 | 30 | 0.070 |
Why?
|
| B-Cell Activating Factor | 1 | 2007 | 9 | 0.070 |
Why?
|
| Peritoneum | 1 | 2006 | 30 | 0.070 |
Why?
|
| PAX5 Transcription Factor | 1 | 2006 | 13 | 0.060 |
Why?
|
| Protein Methyltransferases | 1 | 2006 | 14 | 0.060 |
Why?
|
| Recombinant Proteins | 2 | 2003 | 701 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 2 | 1999 | 413 | 0.060 |
Why?
|
| Restriction Mapping | 3 | 1990 | 52 | 0.060 |
Why?
|
| Antibody Diversity | 1 | 2005 | 8 | 0.060 |
Why?
|
| Plasmids | 1 | 2006 | 291 | 0.060 |
Why?
|
| Luciferases | 2 | 1998 | 107 | 0.060 |
Why?
|
| Immunoglobulin Allotypes | 1 | 1985 | 2 | 0.060 |
Why?
|
| Germ Cells | 2 | 1999 | 110 | 0.060 |
Why?
|
| Immunoglobulin M | 3 | 1992 | 115 | 0.060 |
Why?
|
| Lymphoma | 1 | 1985 | 102 | 0.060 |
Why?
|
| DNA Nucleotidylexotransferase | 1 | 2003 | 12 | 0.050 |
Why?
|
| Base Composition | 1 | 2003 | 30 | 0.050 |
Why?
|
| Transfection | 2 | 1998 | 692 | 0.050 |
Why?
|
| Genetic Variation | 1 | 2004 | 383 | 0.050 |
Why?
|
| Signal Transduction | 3 | 2013 | 3033 | 0.050 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1998 | 11 | 0.040 |
Why?
|
| STAT6 Transcription Factor | 1 | 1998 | 7 | 0.040 |
Why?
|
| Glutathione Transferase | 1 | 1998 | 41 | 0.040 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 1998 | 24 | 0.040 |
Why?
|
| Transcription Factor RelA | 1 | 1998 | 50 | 0.040 |
Why?
|
| Drug Synergism | 1 | 1998 | 142 | 0.040 |
Why?
|
| Exons | 1 | 1999 | 199 | 0.040 |
Why?
|
| Cell Division | 1 | 1999 | 449 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 1998 | 255 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 1998 | 453 | 0.030 |
Why?
|
| Cell Survival | 1 | 1999 | 569 | 0.030 |
Why?
|
| Cell Cycle | 1 | 1999 | 389 | 0.030 |
Why?
|
| Chromosome Deletion | 2 | 1989 | 42 | 0.030 |
Why?
|
| Immunoglobulin E | 2 | 1988 | 80 | 0.030 |
Why?
|
| Antibody Specificity | 1 | 1996 | 102 | 0.030 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 1995 | 28 | 0.030 |
Why?
|
| Antigens | 1 | 1996 | 147 | 0.030 |
Why?
|
| Consensus Sequence | 1 | 1995 | 30 | 0.030 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 1995 | 28 | 0.030 |
Why?
|
| Fanconi Anemia Complementation Group D2 Protein | 1 | 2014 | 6 | 0.030 |
Why?
|
| Fanconi Anemia Complementation Group A Protein | 1 | 2014 | 5 | 0.030 |
Why?
|
| Mitomycin | 1 | 2014 | 26 | 0.030 |
Why?
|
| Lymphocytes | 1 | 1995 | 201 | 0.030 |
Why?
|
| Chromosome Mapping | 2 | 1993 | 289 | 0.030 |
Why?
|
| Female | 2 | 2013 | 32791 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1995 | 363 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 1995 | 300 | 0.030 |
Why?
|
| Chromosome Aberrations | 1 | 2014 | 67 | 0.030 |
Why?
|
| Xanthines | 1 | 1993 | 8 | 0.030 |
Why?
|
| Niacinamide | 1 | 1993 | 33 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 1995 | 371 | 0.030 |
Why?
|
| Proteins | 1 | 1999 | 751 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 1998 | 1007 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1995 | 245 | 0.030 |
Why?
|
| Serine | 1 | 2013 | 91 | 0.030 |
Why?
|
| Cyclic AMP | 1 | 1993 | 143 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2014 | 220 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 1996 | 1592 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1992 | 65 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 1992 | 195 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1992 | 107 | 0.020 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2011 | 81 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2011 | 153 | 0.020 |
Why?
|
| RNA Probes | 1 | 1990 | 9 | 0.020 |
Why?
|
| DNA Probes | 1 | 1990 | 34 | 0.020 |
Why?
|
| Poly A | 1 | 1990 | 26 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 1996 | 1348 | 0.020 |
Why?
|
| Nucleotide Mapping | 1 | 1989 | 2 | 0.020 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 1990 | 72 | 0.020 |
Why?
|
| DNA Breaks, Single-Stranded | 1 | 2009 | 6 | 0.020 |
Why?
|
| Methylation | 1 | 1989 | 129 | 0.020 |
Why?
|
| Interleukins | 1 | 1988 | 80 | 0.020 |
Why?
|
| Kinetics | 1 | 1990 | 760 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 1990 | 566 | 0.020 |
Why?
|
| HeLa Cells | 1 | 1988 | 535 | 0.020 |
Why?
|
| Immunoglobulin Idiotypes | 1 | 1985 | 5 | 0.010 |
Why?
|
| Immunoglobulin alpha-Chains | 1 | 1985 | 3 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2005 | 517 | 0.010 |
Why?
|
| Introns | 1 | 2003 | 111 | 0.010 |
Why?
|
| H-2 Antigens | 1 | 1982 | 67 | 0.010 |
Why?
|
| Hybridomas | 1 | 2001 | 63 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2001 | 117 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1985 | 863 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2003 | 894 | 0.010 |
Why?
|
| Male | 1 | 1990 | 29821 | 0.000 |
Why?
|
| DNA Restriction Enzymes | 1 | 1982 | 34 | 0.000 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1982 | 98 | 0.000 |
Why?
|
| Polymorphism, Genetic | 1 | 1982 | 191 | 0.000 |
Why?
|